Moderna believes its mRNA know-how, which has proven so successful against COVID-19, could also help finally crack the challenge of developing a HIV vaccine, and has just launched a Phase I study with academic partners.
While antiretroviral therapies are able to suppress HIV for a lifetime once individuals are infected, there remains a need for...